Researchers from Leiden have developed a promising TB vaccine that users can self-administer via a special patch. This could be beneficial for countries with limited health services, says PhD candidate Malene Neustrup.

Providing each cancer patient with the right treatment remains a challenge. Oncode Accelerator aims to change this by innovating the way we develop cancer treatments, thus ensuring the patient is at the heart of the process.

Racism and discrimination come in many different shapes and forms – in the Netherlands too. Verbal attacks, stereotypes and violence: some people are confronted with these on a daily basis. A group that is often not included in research and the debate on racism is people of Asian descent. The Diversity…

‘Be yourself. Be as gay, queer, trans as you can and show the world you exist.’ These rousing words from Looi van Kessel marked the start of the third Pride Leiden for the university boat, with the theme: ‘450 years of being yourself’.

The development of the Faculty Strategic Plan (FSP) did not come to a standstill over the summer. We now have a draft version of the Plan that incorporates the feedback on the strategic objectives that we obtained from various meetings and bodies before the summer. The Research Directors and a number…

Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac microtissues. This platform will allow large numbers of drugs to be tested quickly

As robotics advances in the field of emergency response, firefighting robots – or 'firebots' – offer promising improvements in safety and operational efficiency. However, to ensure these technologies truly benefit society, non-technological factors must be considered from the outset.

Arts and leisure, Arts and leisure

A peer educator intervention can give pupils more knowledge and awareness about their LGBT peers, and sometimes also a more positeve view. This is the subject of Marieke Kroneman's dissertation. Defence on 15 September.

Infecting each other with viruses and bacteria while protecting yourself with medicines and vaccinations. Sounds like a fun evening, right? Master students Life Science & Technology Rafael Jezior and Dennis de Beeld certainly think so. Together, they developed ImmunoWars: an exciting card game based…

Leiden University will set up further activities with the Asian Development Bank (ADB).

Leiden University is going to partner with the Asian Development Bank, a bank committed to regional development. President of the Executive Board Annetje Ottow signed a memorandum of understanding on this unique partnership in Manila on 27 April.

At a symposium on 26 May, experts, staff and students from Leiden University will discuss what should happen with Rein Dool’s painting in the Academy Building and what the guidelines for the University’s exhibition policy should be. These issues will be explored from diverse perspectives during the…

Bringing your drug candidates to patients is what many academic chemists dream about, but the road to this goal is long and bumpy. Now, Leiden small molecule nizubaglustat is ready for phase 3 clinical trials. This is thanks to a €132 million funding secured by the biotech spin-out Azafaros.

In healthcare, gender and sex considerations are crucial because they affect individuals' health and disease differences. Yet, most algorithms deployed in the healthcare context lack close consideration of these aspects and do not account for bias detection. In their latest paper, Eduard Fosch-Villaronga,…

Researchers at Leiden University have been awarded a €4 million EU grant to develop climate-neutral fuels. With this money they will expand the broad research community that focuses on green energy. If we work together, we can make the rapid progress that is needed, says Prof. Huub de Groot, Professor…

The Leiden Academic Centre for Drug Research (LACDR) has received a €750,000 grant from ZonMw for QPharmNL. This is a continuing education programme that trains professionals in computational techniques in pharmacology for innovative drug development.

Through its Demonstrator Projects, the Dutch Oncode Accelerator consortium provides grants for preclinical cancer therapy development. The first call for these projects is open until September 2025.